Bone Loss Completed Phase 2 Trials for Teriparatide (DB06285)

Also known as: Osteopenia / Osteopaenia

IndicationStatusPhase
DBCOND0031952 (Bone Loss)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT0202517912 Month Extension Study of the Effect of Teriparatide on Bone in People With Chronic Spinal Cord Injury (SCI)Treatment
NCT01225055Effect of Teriparatide, Vibration and the Combination on Bone Mass and Bone Architecture in Chronic Spinal Cord InjuryTreatment